Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,267 | 149,578 | 15,116 | 41,032 | 42,988 |
| Marketable Securities | 645,074 | 419,026 | 230,636 | 229,176 | 132,915 |
| Other current assets | 55,061 | 20,437 | 20,514 | 11,149 | 10,663 |
| TOTAL | $739,402 | $589,041 | $266,266 | $281,357 | $186,566 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 2,826 | 2,988 |
| Investments And Advances | 339,061 | 162,993 | 0 | 4,837 | 5,371 |
| Other Non-Current Assets | 16,666 | 11,237 | 14,140 | 12,327 | 12,609 |
| TOTAL | $355,727 | $174,230 | $14,140 | $19,990 | $20,968 |
| Total Assets | $1,095,129 | $763,271 | $280,406 | $301,347 | $207,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 24,891 | 10,026 | 10,770 | 15,563 | 14,281 |
| Accrued Expenses | 23,388 | 25,151 | 22,271 | 28,594 | 35,099 |
| TOTAL | $70,985 | $57,708 | $53,536 | $66,340 | $71,391 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 121,023 | 129,347 | 137,038 | 149,921 | 160,354 |
| TOTAL | $121,023 | $129,347 | $137,038 | $149,921 | $160,354 |
| Total Liabilities | $192,008 | $187,055 | $190,574 | $216,261 | $231,745 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,143 | 33,786 | 28,688 | 20,342 | 19,019 |
| Common Shares | 3 | 3 | 2 | 2 | 1 |
| Retained earnings | -3,845,812 | -3,805,190 | -3,760,286 | -3,724,207 | -3,688,685 |
| Other shareholders' equity | -1,756 | -1,034 | 17 | 56 | -14 |
| TOTAL | $903,121 | $576,216 | $89,832 | $85,086 | $-24,211 |
| Total Liabilities And Equity | $1,095,129 | $763,271 | $280,406 | $301,347 | $207,534 |